Prior work supports the sensitivity of laboratory self-administration to detect pharmacotherapy effects
Factors Indicating Need for Dose Escalation Increase doses when minimal subjective improvements after 3-4 weeks at current dose, IGF-1 levels show minimal or no meaningful increase from baseline after an adequate trial period (e.g., 812 weeks), good tolerance without significant side effects suggesting room for higher dosing, and treatment goals require more aggressive approach than current dose provides
Tirzepatide, another GLP-1 receptor agonist, offers similar results but may have different dosing and effects
On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health
WATCH OUR ABC GLOBAL ALLIANCE WEBINAR: "ADVOCACY TOOLS TO IMPROVE ACCESS TO MEDICINES" #EUWeekAgainstCancer #AccessToMedicines #BreastCancer #HealthEquity #TBCT #WomensHealth To view or add a comment, sign in The studies spanned many of the 13 cancers associated with obesity
Microdosing GLP-1s requires a personalized dosing plan that considers the drugs specific pharmacodynamicshow it is absorbed, distributed, metabolized, and eliminated in the bodyand demands consistency and dedication
